National Notifiable Diseases Surveillance System, 1 October to 31 December 2017

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 80,388 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 October to 31 December 2017 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2017, by date of diagnosis*

Table 2: Notifications of diseases received by state and territory health authorities, 1 October to 31 December 2017, by date of diagnosis*

Disease

ACT

NSW

NT

QLD

SA

TAS

VIC

WA

Total current quarter

Total last quarter

Total same period previous year

Last 5 years mean current quarter

Ratio

Year to date

Last 5 years YTD mean

Bloodborne diseases

Hepatitis B (newly acquired) †

0

5

0

8

2

1

8

8

32

33

37

39

0.8

141

167.4

Hepatitis B (unspecified) ‡

17

553

29

201

72

11

416

126

1,425

1,482

1,411

1,544

0.9

5,967

6,446.2

Hepatitis C (newly acquired) †

2

13

0

85

6

5

11

34

156

147

186

157.8

1

610

625.6

Hepatitis C (unspecified) ‡

31

1,041

37

517

82

61

425

266

2,460

2,533

2,796

2,532

1

10,089

10,038.2

Hepatitis D

0

6

0

1

5

0

4

0

16

26

15

12.8

1.3

64

51.2

Gastrointestinal diseases

Botulism

0

1

0

0

1

0

0

0

2

0

0

0.2

10

2

1.6

Campylobacteriosis

142

NN

73

2,139

789

221

1,807

932

6,103

4,999

6,993

5,545.8

1.1

22,385

19,411

Cryptosporidiosis

2

136

17

157

28

12

234

28

614

516

952

708.4

0.9

4,683

3,776.8

Haemolytic uraemic syndrome (HUS)

0

0

0

0

2

0

1

0

3

1

6

4.8

0.6

14

18

Hepatitis A

0

22

0

7

15

0

35

1

80

60

41

41.8

1.9

211

182.2

Hepatitis E

0

4

0

1

0

0

2

0

7

10

15

13.2

0.5

47

41.6

Listeriosis

1

6

0

2

1

0

5

0

15

13

21

21.2

0.7

70

80.6

Paratyphoid

2

10

0

1

2

0

8

0

23

9

17

19.2

1.2

66

75.4

STEC §

0

14

0

7

85

1

12

22

141

116

146

56.2

2.5

490

176.8

Salmonellosis

33

834

137

883

407

96

776

558

3,724

2,569

3,872

3,623.4

1

16,438

15,038.2

Shigellosis

2

65

137

58

20

8

162

69

521

429

362

230

2.3

1,757

913.6

Typhoid Fever

0

10

0

2

1

0

10

10

33

23

25

29.2

1.1

141

121.4

Quarantinable diseases

Avian influenza in humans (AIH)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Cholera

0

1

0

0

0

0

0

0

1

1

1

0.8

1.3

2

2.6

Middle East respiratory syndrome coronavirus (MERS-CoV)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Plague

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Rabies

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Severe acute respiratory syndrome (SARS)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Smallpox

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Viral haemorrhagic fever (NEC)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Yellow fever

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Sexually transmissible infections

Chlamydial infection ||, ¶

369

7,171

678

5,497

1,368

339

2,944

2,702

21,068

22,798

22,586

20,921.8

1

96,352

86,947.2

Donovanosis

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0.4

Gonococcal infection ¶

73

2,266

457

1,139

312

24

1,758

646

6,675

6,713

6,216

4,361.8

1.5

28,411

17,377.4

Syphilis < 2 years ¶

8

265

81

250

40

2

324

87

1,057

1,127

833

587

1.8

4,347

2,319.4

Syphilis > 2 years or unspecified duration ‡, ¶

2

137

22

68

21

0

186

48

484

511

491

429

1.1

2,027

1,779

Syphilis congenital

0

1

0

1

0

0

0

0

2

2

0

0.4

5

8

3.2

Vaccine preventable diseases

Diphtheria

0

0

0

1

0

0

1

1

3

1

3

1

3

8

3

Haemophilus influenzae type b

0

4

1

1

0

0

0

0

6

3

3

3.6

1.7

15

18

Influenza (laboratory confirmed)

272

4,927

223

5,195

4,248

311

4,582

1,464

21,222

207,263

15,034

7,505.8

2.8

249,787

66,406.8

Measles

2

4

0

0

0

0

3

0

9

20

29

38.2

0.2

81

173.8

Mumps

0

37

27

138

3

2

10

5

222

219

110

103.6

2.1

809

410.6

Pertussis

23

1,083

32

337

360

15

517

412

2,779

3,099

5,571

5,532.6

0.5

12,118

18,195.2

Pneumococcal disease (invasive)

9

143

14

59

43

12

106

32

418

870

396

351.4

1.2

2,040

1,620.2

Poliovirus infection

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Rotavirus

0

739

7

527

558

87

0

97

2,015

2,850

855

1,110.6

1.8

7,001

3,316

Rubella

0

1

0

0

0

0

0

0

1

3

1

4.4

0.2

11

21.8

Rubella congenital

0

0

0

0

0

0

0

0

0

0

0

0.2

0

0

0.8

Tetanus

0

0

0

1

0

0

0

0

1

0

1

1.6

0.6

4

4.6

Varicella zoster (chickenpox)

42

NN

17

182

134

13

349

178

915

854

1,001

702.6

1.3

3,153

2,349.4

Varicella zoster (shingles)

82

NN

95

554

662

104

667

508

2,672

2,142

2,106

1,558

1.7

9,128

5,771.2

Varicella zoster (unspecified)

49

NN

1

1,364

93

43

1,784

401

3,735

4,088

3,983

3,303.8

1.1

15,839

12,353.6

Vectorborne diseases

Barmah Forest virus infection

0

22

2

64

1

0

2

16

107

81

68

275

0.4

448

1,533.2

Chikungunya virus infection

0

10

0

3

0

0

10

2

25

31

47

25.8

1

98

97.6

Dengue virus infection

16

87

3

36

6

4

39

33

224

190

339

290.8

0.8

1,070

1,810.8

Flavivirus infection (unspecified)

0

0

0

1

0

0

0

0

1

0

14

4.2

0.2

15

33.6

Japanese encephalitis virus infection

0

0

0

0

0

0

0

0

0

0

0

0.2

0

1

1.8

Malaria

2

11

0

28

1

2

18

7

69

95

76

76.6

0.9

359

325.8

Murray Valley encephalitis virus infection

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0.6

Ross River virus infection

0

121

27

202

13

0

34

165

562

578

1,183

1,085.2

0.5

6,913

5,516.8

West Nile/Kunjin virus infection

0

0

0

0

0

0

0

0

0

2

0

0.6

0

6

0.8

Zoonoses

Anthrax

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Australian bat lyssavirus infection

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0.2

Brucellosis

0

4

0

4

0

0

0

0

8

3

5

4.6

1.7

18

19.8

Leptospirosis

0

2

2

12

0

0

1

1

18

32

21

15.6

1.2

142

95

Lyssavirus infection (NEC)

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Ornithosis

0

0

0

0

0

0

6

0

6

5

13

16.4

0.4

21

40.4

Q fever

0

41

1

43

7

2

6

2

102

98

149

121.6

0.8

454

498.8

Tularaemia

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Other bacterial infections

Legionellosis

0

33

0

21

9

1

36

12

112

71

97

104.2

1.1

385

409.8

Leprosy

0

1

0

2

1

0

0

1

5

2

6

3.6

1.4

10

13.2

Meningococcal disease (invasive)**

0

20

13

16

5

6

24

19

103

141

82

48.6

2.1

382

194.4

Tuberculosis

3

144

7

51

12

3

136

50

406

361

389

363.2

1.1

1,416

1,307.2

1,184

19,995

2,140

19,866

9,415

1,386

17,459

8,943

80,388

267,220

78,604

506,054

*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.†Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.¶ The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).** Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.
NN Not notifiable
NEC Not elsewhere classified
Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.

Table 3: Notification rates of diseases, 1 October to 31 December 2017, by state or territory. (Annualised rate per 100,000 population)*,†

Table 3: Notification rates of diseases, 1 October to 31 December 2017, by state or territory. (Annualised rate per 100,000 population)*,†

1Disease

ACT

NSW

NT

QLD

SA

TAS

VIC

WA

Australia

Bloodborne diseases

Hepatitis B (newly acquired) ‡

0.0

0.3

0.0

0.7

0.5

0.8

0.5

1.3

0.5

Hepatitis B (unspecified) §

16.9

28.6

47.2

16.6

16.8

8.5

26.9

19.7

23.5

Hepatitis C (newly acquired) ‡

2.0

0.7

0.0

7.0

1.4

3.9

0.7

5.3

2.6

Hepatitis C (unspecified) §

30.7

53.8

60.2

42.6

19.1

47.1

27.5

41.6

40.6

Hepatitis D

0.0

0.3

0.0

0.1

1.2

0.0

0.3

0.0

0.3

Gastrointestinal diseases

Botulism

0.0

0.1

0.0

0.0

0.2

0.0

0.0

0.0

0.0

Campylobacteriosis

140.8

NN

118.8

176.5

184.2

170.8

117.0

145.7

148.2

Cryptosporidiosis

2.0

7.0

27.7

13.0

6.5

9.3

15.1

4.4

10.1

Haemolytic uraemic syndrome (HUS)

0.0

0.0

0.0

0.0

0.5

0.0

0.1

0.0

0.0

Hepatitis A

0.0

1.1

0.0

0.6

3.5

0.0

2.3

0.2

1.3

Hepatitis E

0.0

0.2

0.0

0.1

0.0

0.0

0.1

0.0

0.1

Listeriosis

1.0

0.3

0.0

0.2

0.2

0.0

0.3

0.0

0.2

Paratyphoid

2.0

0.5

0.0

0.1

0.5

0.0

0.5

0.0

0.4

STEC ||

0.0

0.7

0.0

0.6

19.8

0.8

0.8

3.4

2.3

Salmonellosis

32.7

43.1

223.0

72.8

95.0

74.2

50.2

87.2

61.5

Shigellosis

2.0

3.4

223.0

4.8

4.7

6.2

10.5

10.8

8.6

Typhoid Fever

0.0

0.5

0.0

0.2

0.2

0.0

0.6

1.6

0.5

Quarantinable diseases

Avian influenza in humans (AIH)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Cholera

0.0

0.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Middle East respiratory syndrome coronavirus (MERS-CoV)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Plague

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rabies

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Severe acute respiratory syndrome (SARS)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Smallpox

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Viral haemorrhagic fever (NEC)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Yellow fever

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Sexually transmissible infections

Chlamydial infection ¶**

365.8

370.6

1,103.6

453.5

319.4

262.0

190.6

422.4

348.1

Donovanosis

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Gonococcal infection**

72.4

117.1

743.9

94.0

72.9

18.5

113.8

101.0

110.3

Syphilis < 2 years **

7.9

13.7

131.8

20.6

9.3

1.5

21.0

13.6

17.5

Syphilis > 2 years or unspecified duration §**

2.0

7.1

35.8

5.6

4.9

0.0

12.0

7.5

8.0

Syphilis congenital

0.0

0.1

0.0

0.1

0.0

0.0

0.0

0.0

0.0

2Vaccine preventable diseases

Diphtheria

0.0

0.0

0.0

0.1

0.0

0.0

0.1

0.2

0.0

Haemophilus influenzae type b

0.0

0.2

1.6

0.1

0.0

0.0

0.0

0.0

0.1

Influenza (laboratory confirmed)

269.7

254.6

363.0

428.6

991.9

240.3

296.6

228.8

350.6

Measles

2.0

0.2

0.0

0.0

0.0

0.0

0.2

0.0

0.1

Mumps

0.0

1.9

43.9

11.4

0.7

1.5

0.6

0.8

3.7

Pertussis

22.8

56.0

52.1

27.8

84.1

11.6

33.5

64.4

45.9

Pneumococcal disease (invasive)

8.9

7.4

22.8

4.9

10.0

9.3

6.9

5.0

6.9

Poliovirus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rotavirus

0.0

38.2

11.4

43.5

130.3

67.2

0.0

15.2

33.3

Rubella

0.0

0.1

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Rubella congenital

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Tetanus

0.0

0.0

0.0

0.1

0.0

0.0

0.0

0.0

0.0

Varicella zoster (chickenpox)

41.6

NN

27.7

15.0

31.3

10.0

22.6

27.8

22.2

Varicella zoster (shingles)

81.3

NN

154.6

45.7

154.6

80.4

43.2

79.4

64.9

Varicella zoster (unspecified)

48.6

NN

1.6

112.5

21.7

33.2

115.5

62.7

90.7

Vectorborne diseases

Barmah Forest virus infection

0.0

1.1

3.3

5.3

0.2

0.0

0.1

2.5

1.8

Chikungunya virus infection

0.0

0.5

0.0

0.2

0.0

0.0

0.6

0.3

0.4

Dengue virus infection

15.9

4.5

4.9

3.0

1.4

3.1

2.5

5.2

3.7

Flavivirus infection (unspecified)

0.0

0.0

0.0

0.1

0.0

0.0

0.0

0.0

0.0

Japanese encephalitis virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Malaria

2.0

0.6

0.0

2.3

0.2

1.5

1.2

1.1

1.1

Murray Valley encephalitis virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Ross River virus infection

0.0

6.3

43.9

16.7

3.0

0.0

2.2

25.8

9.3

West Nile/Kunjin virus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Zoonoses

Anthrax

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Australian bat lyssavirus infection

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Brucellosis

0.0

0.2

0.0

0.3

0.0

0.0

0.0

0.0

0.1

Leptospirosis

0.0

0.1

3.3

1.0

0.0

0.0

0.1

0.2

0.3

Lyssavirus infection (NEC)

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Ornithosis

0.0

0.0

0.0

0.0

0.0

0.0

0.4

0.0

0.1

Q fever

0.0

2.1

1.6

3.5

1.6

1.5

0.4

0.3

1.7

Tularaemia

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

0.0

Other bacterial infections

Legionellosis

0.0

1.7

0.0

1.7

2.1

0.8

2.3

1.9

1.9

Leprosy

0.0

0.1

0.0

0.2

0.2

0.0

0.0

0.2

0.1

Meningococcal disease (invasive)††

0.0

1.0

21.2

1.3

1.2

4.6

1.6

3.0

1.7

Tuberculosis

3.0

7.4

11.4

4.2

2.8

2.3

8.8

7.8

6.7

*The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.†Rate per 100,000 of population. Annualisation Factor was 4.0‡Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland began reporting hepatitis C newly acquired from 1 September 2016. Previous notifications are reported under hepatitis unspecified.§Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.||Infection with Shiga toxin/verotoxin-producing Escherichia coli.¶Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.**The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).††Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital
Territory also report conjunctival cases.
NEC Not elsewhere classified.
NN Not notifiable.